{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:29:44Z","timestamp":1790958584055,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2262,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/modpathol.2016.128","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T07:51:21Z","timestamp":1469778681000},"page":"1313-1323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Ji-Young","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heounjeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.128_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/cmi.2011.60","article-title":"Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance","volume":"9","author":"Jin","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1038\/modpathol.2016.128_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/imr.12306","article-title":"Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity","volume":"266","author":"Humphries","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1038\/modpathol.2016.128_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/imr.12298","article-title":"E3 ubiquitin ligases Pellinos as regulators of pattern recognition receptor signaling and immune responses","volume":"266","author":"Medvedev","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1038\/modpathol.2016.128_bib4","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1172\/JCI75667","article-title":"Pellino 1 promotes lymphomagenesis by deregulating BCL6 polyubiquitination","volume":"124","author":"Park","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2016.128_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/ni.2090","article-title":"The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity","volume":"12","author":"Chang","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1038\/modpathol.2016.128_bib6","unstructured":"Steven HS, Elias C, Nancy LH et al, (eds). WHO classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC: Lyon, 2008."},{"key":"10.1038\/modpathol.2016.128_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jclinpath-2014-202434","article-title":"Sonic hedgehog signalling proteins are frequently expressed in retinoblastoma and are associated with aggressive clinicopathological features","volume":"68","author":"Choe","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2016.128_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.128_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbagrm.2014.06.002","article-title":"Myc and its interactors take shape","volume":"1849","author":"Tu","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/modpathol.2016.128_bib10","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.1411713112","article-title":"The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc","volume":"112","author":"Sun","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.128_bib11","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1182\/blood.V95.6.2104","article-title":"c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover","volume":"95","author":"Bahram","year":"2000","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.128_bib12","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2016.128_bib13","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.128_bib14","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification","volume":"122","author":"Ott","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.128_bib15","doi-asserted-by":"crossref","first-page":"G535","DOI":"10.1152\/ajpgi.00338.2009","article-title":"MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling","volume":"298","author":"Marquez","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016128","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:49:51Z","timestamp":1760230191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0893395222015198"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.128","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}